Transgene SA reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was EUR 4.76 million compared to EUR 6.09 million a year ago. Net loss was EUR 15.9 million compared to EUR 15.28 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.348 EUR | +0.15% | +8.36% | -1.61% |
10/04 | Transgene: presents vaccine results at AACR | CF |
28/03 | Transgene CFO Steps Down; Successor Assumes Office | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-1.61% | 146M | |
+3.72% | 108B | |
+11.12% | 104B | |
+1.28% | 22.33B | |
-12.82% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-10.42% | 17.64B | |
+3.83% | 14.05B | |
+36.77% | 12.51B |
- Stock Market
- Equities
- TNG Stock
- News Transgene
- Transgene SA Reports Earnings Results for the Half Year Ended June 30, 2023